Yantai Dongcheng Pharmaceutical Co Ltd (002675) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.042x

Based on the latest financial reports, Yantai Dongcheng Pharmaceutical Co Ltd (002675) has a cash flow conversion efficiency ratio of 0.042x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥239.54 Million ≈ $35.05 Million USD) by net assets (CN¥5.66 Billion ≈ $827.65 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 002675 company net worth for the company's overall valuation and market capitalisation.

Yantai Dongcheng Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Yantai Dongcheng Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Yantai Dongcheng Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Yantai Dongcheng Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Explore 002675 cash flow quality score to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Sunonwealth Electric Machine Industry Co Ltd
TW:2421
0.043x
Virgin Australia Holdings Ltd
AU:VGN
-0.244x
SKYWORTH GRP UNSP.ADR/30
F:KYW0
N/A
Kelt Exploration Ltd.
TO:KEL
0.048x
Kyland Technology Co Ltd
SHE:300353
-0.023x
BlackRock Capital Allocation Trust
NYSE:BCAT
N/A
Ardent Health Partners, Inc.
NYSE:ARDT
0.078x
Avi Ltd
JSE:AVI
0.245x

Annual Cash Flow Conversion Efficiency for Yantai Dongcheng Pharmaceutical Co Ltd (2008–2025)

The table below shows the annual cash flow conversion efficiency of Yantai Dongcheng Pharmaceutical Co Ltd from 2008 to 2025. View current stock price of Yantai Dongcheng Pharmaceutical Co Ltd for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥5.66 Billion
≈ $827.65 Million
CN¥584.61 Million
≈ $85.55 Million
0.103x +93.35%
2024-12-31 CN¥5.37 Billion
≈ $786.01 Million
CN¥287.15 Million
≈ $42.02 Million
0.053x +4.15%
2023-12-31 CN¥5.40 Billion
≈ $789.55 Million
CN¥276.94 Million
≈ $40.53 Million
0.051x -72.79%
2022-12-31 CN¥5.28 Billion
≈ $772.97 Million
CN¥996.54 Million
≈ $145.82 Million
0.189x +0.44%
2021-12-31 CN¥5.02 Billion
≈ $735.14 Million
CN¥943.58 Million
≈ $138.08 Million
0.188x +62.89%
2020-12-31 CN¥4.97 Billion
≈ $726.63 Million
CN¥572.58 Million
≈ $83.79 Million
0.115x -20.87%
2019-12-31 CN¥4.78 Billion
≈ $699.31 Million
CN¥696.38 Million
≈ $101.90 Million
0.146x +36.26%
2018-12-31 CN¥4.61 Billion
≈ $674.68 Million
CN¥493.06 Million
≈ $72.15 Million
0.107x +68.33%
2017-12-31 CN¥3.29 Billion
≈ $481.25 Million
CN¥208.94 Million
≈ $30.57 Million
0.064x -0.18%
2016-12-31 CN¥3.08 Billion
≈ $451.28 Million
CN¥196.28 Million
≈ $28.72 Million
0.064x +113.39%
2015-12-31 CN¥2.24 Billion
≈ $327.19 Million
CN¥66.69 Million
≈ $9.76 Million
0.030x -32.08%
2014-12-31 CN¥1.18 Billion
≈ $173.30 Million
CN¥52.00 Million
≈ $7.61 Million
0.044x +334.72%
2013-12-31 CN¥1.10 Billion
≈ $161.16 Million
CN¥-20.60 Million
≈ $-3.01 Million
-0.019x -142.66%
2012-12-31 CN¥1.02 Billion
≈ $148.60 Million
CN¥44.53 Million
≈ $6.52 Million
0.044x -90.38%
2011-12-31 CN¥304.42 Million
≈ $44.55 Million
CN¥138.83 Million
≈ $20.31 Million
0.456x +52.81%
2010-12-31 CN¥191.06 Million
≈ $27.96 Million
CN¥57.02 Million
≈ $8.34 Million
0.298x +257.54%
2009-12-31 CN¥140.43 Million
≈ $20.55 Million
CN¥-26.60 Million
≈ $-3.89 Million
-0.189x -136.16%
2008-12-31 CN¥79.34 Million
≈ $11.61 Million
CN¥41.57 Million
≈ $6.08 Million
0.524x --

About Yantai Dongcheng Pharmaceutical Co Ltd

SHE:002675 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.50 Billion
CN¥10.28 Billion CNY
Market Cap Rank
#7266 Global
#1559 in China
Share Price
CN¥12.47
Change (1 day)
-0.87%
52-Week Range
CN¥12.24 - CN¥16.03
All Time High
CN¥27.09
About

Yantai Dongcheng Pharmaceutical Group Co.,Ltd. engages in the raw materials, formulations, nuclear medicine, and big health businesses in China and internationally. It operates through API, Formulation, Radio Pharmaceutical, and Others segments. The company offers formulation products, such as powder injections, tablets, capsules, granules, and drop pills for anticoagulation, cardiovascular, anti… Read more